News
arGEN-X is awarded €1.3 million IWT Grant to Advance Proprietary SIMPLE Antibody™ Platform for Addressing Challenging Disease Targets
arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B round
Events
Bio-Europe Spring 2012, March 19-21, 2012, Amsterdam, The Netherlands http://www.ebdgroup.com/bes/index.php
BioCapital Europe 2012, Thursday April 19, Amsterdam, The Netherlands http://www.biocapitaleurope.com/BioCapitalEurope/